CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 133 enrolled
Drug / intervention
Stimulant or sedative +2 moredrug
Likely dose
Not stated in record
Key inclusion· 3
  • ✓History of past stimulant use
  • ✓BMI between 19 and 26
  • ✓Women must be on hormonal birth control
Key exclusion· 1
  • ✕Major Axis I disorder within the past year

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03075501
NCT03075501Phase 4Completed
CompareCT.gov

Drug Contextual Conditioning With in Humans: Causes and Consequences

University of Illinois at Chicago·interventional·Posted Mar 9, 2017·Updated May 19, 2021

In Brief

A Phase 4 clinical trial evaluating Paired, Stimulant or sedative, and 1 other intervention for Substance-Related Disorders. Completed, enrolled 133 participants across 1 site.

Detailed Summary

The purpose of the study is to determine how associations between drugs and the places where they are experienced influence drug seeking, mood and acute drug responses.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSubstance-Related Disorders
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)

Timeline

Phase 4CompletedFinished
20162017201820192020202120222023202420252026
First PostedMar 9, 2017
Enrollment StartNov 1, 2015
Primary CompletionJul 1, 2020
TodayJul 2, 2026
Enrollment to primary: 4.7 yearsPosted 9.3 years ago

Interventions

Pairedbehavioral

Drug conditioning is assessed by pairing drug administration with a given context.

Stimulant or sedativedrug

CS+ for paired, CS0 for unpaired

Placebodrug

CS- for paired, CS0 for unpaired